Orthofix Medical Inc.
OFIX
$10.51
$0.252.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.99% | 2.59% | 2.85% | 4.31% | 4.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.99% | 2.59% | 2.85% | 4.31% | 4.84% |
| Cost of Revenue | -2.88% | -4.04% | -0.83% | 0.70% | 1.40% |
| Gross Profit | 5.60% | 5.62% | 4.54% | 5.94% | 6.46% |
| SG&A Expenses | 4.01% | 4.13% | 4.04% | 4.99% | 3.10% |
| Depreciation & Amortization | -28.43% | -25.26% | -17.92% | -10.47% | -1.23% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.10% | -0.58% | 0.97% | 2.52% | 1.88% |
| Operating Income | 38.22% | 35.28% | 19.10% | 15.46% | 24.48% |
| Income Before Tax | 50.87% | 57.75% | 26.69% | -1.82% | -4.02% |
| Income Tax Expenses | 42.94% | -77.82% | -34.87% | -71.97% | -60.27% |
| Earnings from Continuing Operations | 50.11% | 58.06% | 26.83% | -0.08% | -2.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.11% | 58.06% | 26.83% | -0.08% | -2.67% |
| EBIT | 38.22% | 35.28% | 19.10% | 15.46% | 24.48% |
| EBITDA | 70.65% | 917.48% | 193.13% | 176.99% | 147.50% |
| EPS Basic | 51.77% | 59.39% | 29.06% | 3.26% | 0.85% |
| Normalized Basic EPS | 35.65% | 47.13% | 40.49% | 13.59% | 15.71% |
| EPS Diluted | 51.55% | 59.17% | 28.91% | 3.16% | 0.75% |
| Normalized Diluted EPS | 35.65% | 47.13% | 40.49% | 13.59% | 15.71% |
| Average Basic Shares Outstanding | 3.36% | 3.45% | 3.60% | 3.70% | 3.70% |
| Average Diluted Shares Outstanding | 3.36% | 3.45% | 3.60% | 3.70% | 3.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |